Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Return of the Pancreas: Evaluating Impact of CFTR Modulators on Pancreatic Function

NCT07632768 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT07632768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Return of the Pancreas: Evaluating Impact of CFTR Modulators on Pancreatic Function
Lead sponsor
Indiana University
Phase
Phase 4
Overall status
Completed
Start date
December 3, 2024
Completion date
January 21, 2026
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cftr gene mutation, cystic fibrosis (cf), exocrine pancreatic insufficiency, exocrine pancreatic insufficiency in subjects with cystic fibrosis, pancreas disease, pancreatic insufficiency